Filing Details
- Accession Number:
- 0001209191-21-018770
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2021-03-08 19:42:33
- Reporting Period:
- 2020-12-23
- Accepted Time:
- 2021-03-08 19:42:33
- Original Submission Date:
- 2020-12-28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1759425 | Mirum Pharmaceuticals Inc. | MIRM | Pharmaceutical Preparations (2834) | 831281555 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1780080 | Ian Clements | C/O Mirum Pharmaceuticals, Inc. 950 Tower Lane, Suite 1050 Foster City CA 94404 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-12-23 | 1,592 | $18.65 | 7,871 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This Form 4 is being amended to correct the number of shares purchased and the amount of securities beneficially owned following the reported transaction.